Tesamorelin (90 Day)

Use tesamorelin within a clearly defined medical plan.

Approved-use context: The branded Tesamorelin product is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. It stimulates growth-hormone release and can reduce visceral abdominal fat.

What to expect: Your clinician should confirm whether treatment matches the approved population or is being considered off-label. Screening and monitoring should address active cancer, pregnancy, pituitary problems, glucose intolerance or diabetes, IGF-1, swelling, joint symptoms, and injection reactions.